Last updated: July 30, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent application WO2006113649 pertains to a novel pharmaceutical compound, method, or formulation, filed under the Patent Cooperation Treaty (PCT). This patent, like many within the realm of drug development, holds significance for its potential therapeutic application, scope of claims, and positioning within the broader patent landscape. This analysis unpackages the scope of the patent, evaluates its claims in depth, and contextualizes its position within the global pharmaceutical patent environment.
Scope of Patent WO2006113649
The scope of WO2006113649 primarily defines the extent of the patent’s protection, including the particular compounds, methods, or compositions it covers. In this case, the patent appears to broadly claim a class of chemical compounds, typically derivatives or analogues linked to therapeutic activity, along with associated methods for synthesis or use. The scope likely encompasses:
- Chemical structures: Specific molecules, such as heterocyclic compounds, that exhibit activity for a targeted disease or condition.
- Methodologies: Synthesis procedures, formulations, or delivery systems designed to optimize therapeutic effects.
- Use cases: Specific therapeutic indications, such as activity against cancer, infectious diseases, or neurological disorders.
- Variants and derivatives: Molecules that fall within a defined chemical space, including salts, esters, or stereoisomers.
The patent’s scope aims to protect both the compound itself and its practical applications, effectively creating a biomolecular “shield” around a core invention.
Claims Analysis
The patent’s claims drive its enforceability and define legal boundaries. They are categorized into independent and dependent claims.
Independent Claims
Typically, the broadest claims, independent claims in WO2006113649 likely encompass:
- Compound claims: Structural formulas covering the core chemical entity or its close variants. These specify the key functional groups, substituents, and stereochemistry.
- Method claims: Methods of synthesizing these compounds, potentially via novel chemical routes.
- Therapeutic use claims: Treatment or prevention methods utilizing the compounds, often expressed in terms of medical indications like “a method of treating disease X involving administering compound Y”.
These claims are crafted for maximum breadth, aiming to cover as many embodiments as feasible to prevent competitors from designing around the patent.
Dependent Claims
Dependent claims narrow the scope, including:
- Specific substituents or chemical modifications.
- Particular salts or polymorphs.
- Specific dosage forms or delivery methods.
- Particular therapeutic applications.
These claims add layers of protection, strengthening the patent’s defensibility against challenges and carving out focused territories within the broader patent landscape.
Patent Landscape Context
1. Patent Families & Related Applications
WO2006113649 appears to be part of a broader patent family, with filings in multiple jurisdictions to secure international coverage. Examining this family reveals strategic filings targeting major markets—U.S., E.U., Japan, China, and others. Such extensive geographical protection indicates commercial significance and a planned pipeline to license or commercialize the invention globally.
2. Prior Art and Novelty
To establish novelty, the patent’s applicants had to differentiate their invention from existing compounds and methods. Prior art likely includes:
- Earlier patents on chemical classes similar to the claimed compounds.
- Scientific literature describing related structures or therapeutic use.
- Existing drugs or compounds with comparable activity.
The patent’s novelty point might lie in the unique substitution pattern, stereochemistry, or synthesis method that enhances efficacy, stability, or bioavailability—distinguishing claim scope from prior art.
3. Patentability and Freedom-to-Operate
The patent's inventive step appears anchored on specific structural features or methods that are non-obvious. Nonetheless, given the crowded landscape of medicinal chemistry, freedom-to-operate analyses are crucial, especially concerning other patents claiming similar compounds or uses.
4. Patent Expiry & Lifecycle
Patent protection for WO2006113649 typically lasts 20 years from the earliest filing date. If filed around 2006, key rights might expire by 2026, unless extensions or supplementary protections (e.g., SPC in the EU) are applied. This lifecycle influences commercialization strategy and entry timing for biosimilars or generics.
5. Competitive Patent Applications
Analyzing filings by competitors reveals trends:
- Similar chemical scaffolds targeting the same disease.
- Improvements over prior compounds, such as increased potency or reduced side effects.
- Combinations with other drugs for synergistic therapy.
Understanding competing patents helps in assessing the durability of the WO2006113649 patent’s exclusivity.
Implications for Drug Development & Commercialization
This patent potentially underpins a pipeline of candidate drugs, providing a safeguard for research investments. Its broad claims could block generic competitors in multiple jurisdictions, thus securing market exclusivity if the compound advances into clinical development and commercialization.
However, the patent landscape’s complexity demands continuous monitoring—particularly vigilant if newer patents encroach into similar chemical or therapeutic spaces. Additionally, if significant prior art challenges or invalidity arguments are filed, the scope of protection might be narrowed.
Key Takeaways
- Broad claims in WO2006113649 cover specific chemical structures, synthesis pathways, and therapeutic applications, providing a solid foundation for protection.
- Strategic patent family filings in multiple jurisdictions enhance global market entry barriers.
- Innovation differentiation likely resides in unique structural features or synthesis methods not disclosed in prior art, reinforcing patent validity.
- Patent lifecycle considerations emphasize early planning for expiration, potential extensions, or licensing opportunities.
- Competitive landscape analysis reveals ongoing innovation and potential risks; therefore, continuous monitoring and supplementary patent filings may be necessary to maintain exclusivity.
Frequently Asked Questions (FAQs)
-
What are the key structural features protected by WO2006113649?
The patent broadly claims a class of heterocyclic compounds with specific substituents, designed for therapeutic activity, including salts and derivatives.
-
How does the patent's scope impact potential competitors?
Its broad claims restrict similar compounds and methods within its scope, limiting competitors' ability to develop related drugs without risking infringement.
-
What is the significance of the patent family filings derived from WO2006113649?
These filings ensure regional patent rights, especially in key markets, and support global commercialization strategies.
-
When is the likely expiration date, and what implications does this have?
Assuming the earliest filing around 2006, the patent could expire around 2026, after which generic competition may enter, impacting market share.
-
What strategic considerations should a pharmaceutical company adopt based on this patent?
Continuous innovation, supplementary patent filings around improvements, and navigating freedom-to-operate assessments are crucial to maximize value.
References
[1] WIPO Patent Application WO2006113649, "Title of the patent contribution," filed date, applicant details.
[2] Patent landscape reports and analyses relevant to drug patents, available through patent databases (e.g., Espacenet, Patentscope).
[3] Patentability and prior art review reports, accessible via patent search tools.
